ABOUT US
Repligen is a bioprocessing-focused life sciences company bringing over 40 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies.
Repligen headquarters is in Waltham, Massachusetts and our manufacturing facilities are located around the world. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.
FEATURED INSIGHTS
-
![GettyImages-1288978528 Scientist Using Microscope In Lab]( "Simpler, Faster, Cheaper Advanced Therapy Manufacturing")
Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.
-
![GettyImages-2193840533-adenovirus]( "Simplified LV And AAV Clarification With TFDF-Based Intensified Virus Production")
Learn how Tangential Flow Depth Filtration (TFDF) enhances viral vector production, streamlining the clarification process and increasing efficiency and yield for LV and AAV manufacturing.
-
![Repligen - XCell lab]( "Disruptive Technologies Transforming Upstream Process Intensification For All Modalities")
The demand for complex biologics is driving the need for intensified cell culture technologies. Perfusion using alternating tangential flow (ATF) has emerged as a leading solution to increase cell density and productivity.
-
![Worker Holding Vaccine Vial GettyImages-1403976499]( "Exploring Perfusion Technology For Virus Manufacturing Process Intensification")
Perfusion cell culture technology supports high cell densities and product yields for viral vaccine manufacturing, offering a reliable way to produce high-quality cells at a commercial scale.
CONTACT INFORMATION
Repligen
41 Seyon Street, Building 1, Suite 100
Waltham, MA 02453
UNITED STATES
Phone: 781-250-0111
SOLUTIONS
-
![Repligen - XCell screen]( "A Scaled-Down Solution For Simple, Robust Upstream Intensification")
Learn about a system that enables simple, fast, cost-effective, and scalable upstream intensification development. It delivers precise flow rates, even at high cell densities and viscosities.
-
![Repligen - XCell]( "XCell® ATF System: Breaking Productivity Barriers In Upstream Bioprocessing")
Learn about innovative cell retention technology that supports continuous bioprocessing through perfusion cell culture, allowing for longer run times, higher product yields, and reduced costs.
